esottransplant
banner
esottransplant.bsky.social
esottransplant
@esottransplant.bsky.social
European Society for Organ Transplantation
Pinned
Sensitised transplant candidates face longer waiting time, higher mortality & increased rejection. ENGAGE tackles pre and post-transplant management through well-defined humoral risk stratification & evidence-based care.
See the ENGAGE II report & stay tuned to learn more about ENGAGE III.
ESOT ENGAGE II
International Workshop on Immunomodulation and Desensitisation, scientific report
go.esot.org
⏳ Reminder: Apply now for HESPERIS Course 2026 (16–18 April, Rotterdam)!​
Top-level transplant training, limited to 45 places.​
🗓️ Deadline: 𝟭𝟱 𝗗𝗲𝗰​
Apply via email: [email protected]

#ESOTeducation
HESPERIS Course 2026 • ESOT
go.esot.org
November 25, 2025 at 6:00 AM
Online workshop on complex CMV infection in SOT.​
9️⃣ Dec, 18:00 to 19:30.​
Real cases, resistance issues, treatment optimisation, expert insights.​

🟩 Free registration via the 🔗

#CMV #ESOTeducation​
Complex scenarios in the management of CMV infection in solid organ transplantation
The workshop will be held as an interactive online meeting and participation is limited to 50 attendees.
go.esot.org
November 24, 2025 at 7:00 PM
📢 Don’t miss ESOT’s #CLAD Webinar on 17 Dec!​
💡 Diagnosis, AI, biomarkers, and future trials​
🎓 Top experts across Europe​
🆓 Free | 🖱️ Register: go.esot.org/sp_clad_w1_2025

#LungTransplantation w/ Sanofi​
Chronic Lung Allograft Dysfunction Today
Gaps, Challenges, and Future Directions in Lung Transplant Care
go.esot.org
November 19, 2025 at 8:00 AM
🚀 Applications now open for HESPERIS Course 2026!​
📅 16–18 April, Rotterdam​
A top-level course for early-career transplant professionals.​
Limited to 45 participants.​
🚨 Deadline: 𝟭𝟱 𝗗𝗲𝗰​
Apply: CV + motivation + HoD letter 📨 [email protected]
#ESOTeducation
HESPERIS Course 2026 • ESOT
go.esot.org
November 18, 2025 at 6:00 AM
🎥 Webinar recording now available!
Catch up on the latest insights into PTLD, a rare and complex post-transplant condition.
Experts 🇫🇷🇧🇪🇩🇪 discuss pathogenesis, diagnosis, treatment & emerging therapies.
👉 Watch here: go.esot.org/sp_pf_replay

Supporting global awareness around #RareDiseaseDay
#PTLD
Latest Updates on Post-Transplant Lymphoproliferative Disorders (PTLD)
go.esot.org
November 17, 2025 at 7:00 PM
Reposted by esottransplant
"Efficacy of Intravenous Immunoglobulin in Eliminating De Novo Donor-Specific Antibodies After Lung Transplantation: Importance of Early Intervention"

Read the article here: shorturl.at/tHIXW

#video #abstract #intravenous #immunoglobulin #antibody #lung #transplant @esottransplant.bsky.social
November 15, 2025 at 6:40 PM
🎉 Congratulations to all #EPITAsymposium Elevator Pitch presenters!
Join us on Monday, 26 January, to hear their exciting work first-hand.

👉 Don’t miss it – register now go.esot.org/epitasymp26
November 15, 2025 at 8:00 AM
🫁 #CLAD is the top challenge in long-term #LungTransplant survival.​
ESOT launches a new awareness campaign & education series.​
📘 Learn more: go.esot.org/sp_clad_launch

#LungTransplant #PoweredByESOT
Launching the ESOT CLAD Awareness Webinar Series
ESOT is proud to launch a new webinar series as part of its ongoing awareness campaign on Chronic Lung Allograft Dysfunction (CLAD) — the leading
go.esot.org
November 14, 2025 at 9:00 PM
Reposted by esottransplant
Today is #WorldDiabetesDay.

#Diabetes can affect anyone, at any stage of life.

Support at home, school, work and during pregnancy makes a real difference.

Listen, learn and show up for those living with diabetes. More info 🔗 bit.ly/4hUOjY0
November 14, 2025 at 8:47 AM
Reposted by esottransplant
The treatment of type 1 diabetes is entering a transformative era.

In a Review, Anette-Gabriele Ziegler & colleagues explores three paradigm-shifting developments poised to transform type 1 diabetes treatment: spkl.io/63328Ab7Ay #WorldDiabetesDay
November 14, 2025 at 9:00 AM
Reposted by esottransplant
On this #WorldDiabetesDay, we are proud to highlight how the QUOD Biobank is supporting vital research into diabetes through the QUOD Whole Organ Pancreas Atlas resource.

Link: www.science.org/doi/10.1126/...

#WorldDiabetesDay #DiabetesResearch #QUODBiobank #MedicalResearch #PancreasAtlas
Small things matter: Lack of extraislet β cells in type 1 diabetes
Early loss of small extraislet β cells in children with type 1 diabetes could explain age-related differences in disease.
www.science.org
November 14, 2025 at 9:02 AM
Today on #WorldDiabetesDay, we recognise everyone living with diabetes and the need for continued progress in care.
We are proud to announce the launch of 𝗘𝗣𝗜𝗧𝗥, the European Pancreas & Islet Transplant Registry at the #EPITAsymposium 2026.

Better data for better outcomes.

go.esot.org/epitasymp26
November 14, 2025 at 2:01 PM
🎉 Registration is open for the 15th #EPITAsymposium!
📅 Early bird rates until 28 Nov 2025
💡 ESOT members enjoy extra savings – ensure your membership is up to date.
🔗 go.esot.org/epitasymp26
November 14, 2025 at 6:00 AM
🎉 It’s time!
📬 Abstract notifications are out – check your inbox!

✨ Stay tuned for more highlights coming soon!
Register here go.esot.org/epitasymp26

#EPITAsymposium
November 13, 2025 at 8:01 AM
🚀 Exciting news for the pancreas & islet transplant community!
📅the 15th EPITA Symposium Early bird registration deadline is 28 Nov 2025

👉 Register now go.esot.org/epitasymp26
#EPITAsymposium
November 12, 2025 at 10:54 AM
The 2nd Newsletter from the 𝗟𝗘𝗢𝗣𝗔𝗥𝗗 𝗣𝗿𝗼𝗷𝗲𝗰𝘁 is out 👉 major steps toward transforming liver transplantation across Europe.

From AI-driven decision tools to stronger clinical-research collaboration, LEOPARD is accelerating innovation in how organs are offered & matched.
#ESOT_ELITA #LEOPARD_AI
LEOPARD Project Launches Second Newsletter: Accelerating Innovation in Liver Transplantation — LEOPARD
Discover how the LEOPARD Project is revolutionising liver transplantation through AI, data, and collaboration in its latest newsletter.
www.leopard-project.eu
November 12, 2025 at 8:00 AM
𝗧𝗵𝗲 𝘀𝗲𝗰𝗼𝗻𝗱 #𝗘𝗨𝗥𝗢𝗞𝗘𝗣 𝗡𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿 𝗶𝘀 𝗵𝗲𝗿𝗲!
Highlights include:
– Major milestones across governance, IT & KEPsoft development
– Progress toward the European Kidney Exchange Network (EKEN)
– Upcoming presentations & events

📝 Sign up to receive the latest updates & read: www.hnbts.hu/euro-kep/new...
News & Events | EURO-KEP
We are pleased to announce that the Newsletter Transplant 2025 is now available!This issue also includes the latest kidney transplantation and waiting list data.
www.hnbts.hu
November 11, 2025 at 6:00 AM
Sensitised transplant candidates face longer waiting time, higher mortality & increased rejection. ENGAGE tackles pre and post-transplant management through well-defined humoral risk stratification & evidence-based care.
See the ENGAGE II report & stay tuned to learn more about ENGAGE III.
ESOT ENGAGE II
International Workshop on Immunomodulation and Desensitisation, scientific report
go.esot.org
November 10, 2025 at 7:30 PM
What a day it’s been here in Prague at the 𝗟𝗶𝘃𝗶𝗻𝗴 𝗗𝗼𝗻𝗮𝘁𝗶𝗼𝗻 𝗞𝗶𝗱𝗻𝗲𝘆 𝗧𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗦𝗽𝗲𝗰𝗶𝗮𝗹𝘁𝘆 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗯𝘆 𝗘𝗞𝗜𝗧𝗔 full of insights, innovation, and inspiring discussions!

See you tomorrow 😀

#EKITALivingDonation
November 7, 2025 at 8:54 PM
News from #EKITALivingDonation Symposium!
Insightful discussions, shared experiences, and a common goal: to harmonise practices and improve equity in access to living donation.

📸 Stay tuned for more from Prague!

#ESOT_EKITA @fernandaortiz.bsky.social @frankdor.bsky.social
November 7, 2025 at 11:36 AM
Reposted by esottransplant
"Duodenoduodenostomy as an Attractive Option for Exocrine Drainage in Pancreas Transplantation: Insights From a Single-Center Cohort"

Read more here: shorturl.at/MoMRi

#duodenum #anastomosis #exocrine #drainage #pancreas #transplantation @esottransplant.bsky.social @hospitalclinic.bsky.social
November 6, 2025 at 10:25 AM
Reposted by esottransplant
can viruses 🦠 be superheroes 🦸‍♂️ ?

PhD student Felix Herkner just published the statistical analysis plan
of the TTVguideIT trial 💪👏

Torque Teno virus guided immunosuppression #TTVguide

data cleaning until Q1/26
analysis Q2/26

trialsjournal.biomedcentral.com/articles/10....
Statistical analysis plan for TTVguideIT—a multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and Torque Teno virus-guided immuno...
Background Non-interventional studies indicate an association between Torque Teno Virus (TTV) load in peripheral blood and immunosuppression related outcomes in kidney transplant recipients. This make...
trialsjournal.biomedcentral.com
October 23, 2025 at 5:39 PM
Reposted by esottransplant
Have you seen that actor Jesse Eisenberg is donating his kidney to a stranger? The actor known for The Social Network & a regular blood donor says: ""I think people will realise that it's a no-brainer, if you have the time and the inclination."

www.today.com/health/news/...
EXCLUSIVE: Jesse Eisenberg Reveals He Is Donating a Kidney to a Stranger: 'A No-Brainer'
The "Now You See Me: Now You Don't" star shared the news of his upcoming altruistic kidney donation on TODAY.
www.today.com
October 31, 2025 at 3:42 PM
Reposted by esottransplant
HORUS is featured in Transplant International's Current challenges & advances on Infectious Diseases in Solid Organ Transplantation!

Several consortium members contributed to the publication "Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?"

Read the publication: go.esot.org/WTA8
Frontiers Publishing Partnerships | Current challenges and advances on Infectious Diseases in Solid Organ Transplantation
Infectious complications remain a significant cause of morbidity and mortality after solid organ transplantation (SOT). The implementation of effective preve…
go.esot.org
March 21, 2025 at 5:56 PM